Arab sovereign funds in talks to acquire 20% of ACDIMA’s pharma ingredients production arm

Ahead of launch, Arab SWFs are vying for a slice in ACDIMA’s pharma ingredients producer: Arab sovereign funds are in talks with the Arab Company for Drug Industries and Medical Appliances (ACDIMA) to acquire a 20% share in a new subsidiary it is setting up for producing active pharma ingredients, reportsAl Mal, citing sources it says are in the know. The subsidiary will be responsible for ACDIMA’s new USD 165 mn factory, which will produce 28 active ingredients and is expected to start operations in 2026.

As things stand: ACDIMA will own a 60% stake in the EGP 10 mn company, its subsidiary EIPICO will own 30%, and the Suez Canal Economic Zone (SCZone) will own 10%, according to a provisional ownership structure published (pdf) yesterday by EIPICO. The final shareholder structure could change after the completion of ongoing feasibility studies, the company said.